Prashant Kohli - 28 Aug 2026 Form 4 Insider Report for Grace Therapeutics, Inc. (GRCE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: GRCE
Reported as of: 28 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Sep 2026, 16:05:16 UTC
Prior SEC filing: 16 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert DelAversano as attorney-in-fact for Prashant Kohli

Key filing fact

Prashant Kohli filed Form 4 for Grace Therapeutics, Inc. (GRCE) on 01 Sep 2026.

Key facts

This page summarizes Prashant Kohli's Form 4 filing for Grace Therapeutics, Inc. (GRCE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 16 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001946739 Primary reporting owner

Kohli Prashant

Relationship: Chief Executive Officer, Director
Address: C/O GRACE THERAPEUTICS, INC., 103 CARNEGIE CENTER, SUITE 300, PRINCETON
Signature: /s/ Robert DelAversano as attorney-in-fact for Prashant Kohli
Signature date: 01 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRCE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +267,160
Change %
Price: $0.000000^*
Shares after: 267,160
Date: 28 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 267,160
Exercise price: $2.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date.